FindTrial
Sign In

Platelet rich plasma combined with autogenous bone graft for bone regeneration in bone defects of the comminuted fracture: a Randomized controlled trial study

Platelet rich plasma combined with autogenous bone graft for bone regeneration in bone defects of the comminuted fracture: a Randomized controlled trial study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000927
Enrollment
Unknown
Registered
2010-03-01
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

comminuted fracture

Interventions

1:Platelet rich plasma combined with autogenous bone
2:no (Platelet rich plasma combined with autogenous bone graft) (just operation)

Sponsors

People's Hospital, Kelamayi, Xinjiang, China,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: closed communitate fracture,

Exclusion criteria

Exclusion criteria: open fracture

Design outcomes

Primary

MeasureTime frame
bone union;Wound healing;Nonunion;—

Countries

China

Contacts

Public ContactYue Yong
yueyongenglish@yahoo.com.cn+86 18999505353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026